Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Chronic low-dose: Lower doses (5mg) two to three times weekly suit sustained use without aggressive metabolic intervention
In the context of PBMs, value-based payment models could influence them to prioritize the efficacy and cost-effectiveness of drugs, leading to improved health outcomes and potentially lower healthcare costs
The 2.5 mg starting dose requires only 6.25 units
Sorli C, Harashima S-I, Tsoukas GM et al (2017) Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
US$ 28.55
US$ 19.99
US$ 27.01
US$ 22.82
US$ 27.36
US$ 26.34
US$ 27.52
US$ 22.99
US$ 24.63
